Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221608 | SCV000270600 | likely benign | not specified | 2014-12-19 | criteria provided, single submitter | clinical testing | NEB exons 82-105 are organized in three repetitive blocks of 8 exons each and be cause these blocks are nearly identical in sequence, homologous exons (e.g., exo ns 82, 90, and 98) are co-amplified and sequenced (each amplicon consists of 6 a lleles). This variant represents a nonhomologous position within the three repet itive blocks (c.13353C, c.14811T, and c.16269T). The variable alleles at this po sition are not expected to have clinical significance because these alleles do n ot alter an amino acid residue and are not located within the splice consensus s equence. |
Prevention |
RCV000221608 | SCV000307209 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001572967 | SCV000519875 | likely benign | not provided | 2021-04-02 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001572967 | SCV005255869 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272860 | SCV001455275 | likely benign | Nemaline myopathy 2 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001572967 | SCV001798146 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001572967 | SCV001932981 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572967 | SCV001969439 | likely benign | not provided | no assertion criteria provided | clinical testing |